• OPEN AN ACCOUNT
Indian Indices
Sensex
74,536.07 -366.52
( -0.49%)
Global Indices
Nasdaq
52,089.49 -312.17
(-0.60%)
Dow Jones
7,612.71 -44.65
(-0.58%)
Hang Seng
65,056.24 -86.54
(-0.13%)
Nikkei 225
10,611.90 -58.16
(-0.55%)
Forex
USD-INR
95.06 0.32
(0.34%)
EUR-INR
110.60 0.49
(0.45%)
GBP-INR
128.80 0.53
(0.41%)
JPY-INR
0.62 0.00
(0.59%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
66.2311355
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
57.59
4232.92
EPS(TTM)
Face Value()
Div & Yield %
7.33
1
0.02
 

ruparel food products ltd
Kotia Enterprises reports standalone net loss of Rs 2.22 crore in the March 2026 quarter
May 29,2026
Net Loss of Kotia Enterprises reported to Rs 2.22 crore in the quarter ended March 2026 as against net loss of Rs 0.05 crore during the previous quarter ended March 2025. Sales reported to Rs 1.31 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 2.50 crore in the year ended March 2026 as against net loss of Rs 0.05 crore during the previous year ended March 2025. Sales rose 47.19% to Rs 1.31 crore in the year ended March 2026 as against Rs 0.89 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.310 0 1.310.89 47
OPM %87.020 -51.91-5.62 -
PBDT1.69-0.05 LP 1.41-0.05 LP
PBT1.69-0.05 LP 1.41-0.05 LP
NP-2.22-0.05 -4340 -2.50-0.05 -4900